comprehensive -WSS

comprehensive

author：entertainment 2025-10-02 22:56:33 - browse：86

Ionis Pharmaceuticals, a California biotech that has spearheaded the development of RNA-targeting medicines, announced on Tuesday that its drug against familial chylomicronemia syndrome, a rare and serious disease that prevents the body from breaking down fats, succeeded in a late-stage clinical trial.

The Phase 3 trial, dubbed Balance, enrolled 66 adults who were randomly divided into three groups and given a monthly injection of placebo or one of two doses of olezarsen, the company’s experimental drug. Treatment with the higher dose of the therapy significantly lowered triglycerides in the blood of those on the drug for six months compared to participants given placebo, though a lower dose did not have this effect. Participants on the high dose didn’t have any instances of painful inflammation of the pancreas, one of the disease’s most serious symptoms, while there were 11 such episodes among those on placebo.

Researchers reported that the treatment was also generally safe, with fewer adverse events among those on olezarsen than among the placebo group.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Alkermes shareholders re
Next article： US recommends Americans reconsider traveling to China due to arbitrary law enforcement, exit bans

entertainment

WSS

July 4th fireworks can be stressful for dogs. These 6 tips can keep them calm and safe

1 dead, 9 hurt in July 4th fireworks explosion

Medicare says breakthrough device reimbursement rule to come by summer

Brazil's Neymar fined $3.3 million for illegal artificial lake at mansion outside Rio

Legitimacy of 'customer' in Supreme Court gay rights case raises ethical, legal flags

It shouldn't be easy to buy synthetic DNA to recreate a deadly virus

focus

comprehensive

Wikipedia

Virginia high school admissions case could be legal follow

Medicare says breakthrough device reimbursement rule to come by summer

Tori Bowie and the unacceptable rates of Black maternal death

H5N1 bird flu: what we're starting to learn about infection in cows

In Memoriam: Notable people who died in 2023

How to improve immunocompromised access to mAb treatments

United colonoscopy coverage change 'may cost lives,' doctors say

Churchill Downs extends trainer Bob Baffert's ban through 2024

United colonoscopy coverage change 'may cost lives,' doctors say

First recipient of genetically engineered pig kidney has died

focus

4 dead, 2 in stable condition in Philadelphia shooting: Police

The Democratic Party promised to overhaul its primaries. Doing that has been anything but simple

What nurses really want: sufficient staffing for patient care

Leon Gautier, last member of French D

Bird flu outbreak in cows is latest avian flu curveball

Steward Health Care files for bankruptcy

entertainment

leisure time

leisure time

Wikipedia